Counterfeit Obesity Drugs: A Hidden Danger

This chapter investigates the alarming rise of counterfeit obesity medications, particularly focusing on drugs like Ozempic and Wegovi being sold online and shipped from overseas. It examines the serious health risks posed by fake versions that are hard to distinguish from the real ones and delves into the broader implications for the pharmaceutical industry. The discussion also highlights federal investigations and the complexities surrounding the online trade of these drugs, emphasizing the critical need for consumer awareness and regulatory action.